Previous studies have reported the pro-tumoral effects of CXCL14, based on evidence for the upregulation of CXCL14 in the tumor stroma and CAFs (Allinen et al., 2004; Augsten et al., 2009). The gene discussed is CXCL14; the disease is neoplasm.